Henry Schein’s (HSIC) “Outperform” Rating Reaffirmed at Barrington Research

Henry Schein (NASDAQ:HSIC)‘s stock had its “outperform” rating reiterated by Barrington Research in a report released on Wednesday,Benzinga reports. They currently have a $90.00 price objective on the stock. Barrington Research’s price objective would indicate a potential upside of 24.79% from the company’s current price. Barrington Research also issued estimates for Henry Schein’s Q1 2025 earnings at $1.04 EPS, Q2 2025 earnings at $1.16 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.28 EPS, Q3 2026 earnings at $1.37 EPS, Q4 2026 earnings at $1.43 EPS, FY2026 earnings at $5.22 EPS and FY2027 earnings at $5.65 EPS.

A number of other equities research analysts have also commented on HSIC. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Finally, Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Down 0.6 %

Shares of NASDAQ HSIC opened at $72.12 on Wednesday. The company has a 50 day simple moving average of $74.35 and a 200 day simple moving average of $72.42. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.49. The firm has a market cap of $8.99 billion, a PE ratio of 29.68, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the business posted $0.66 EPS. Henry Schein’s revenue was up 5.8% on a year-over-year basis. On average, research analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Versant Capital Management Inc boosted its position in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Investment Management Corp VA ADV purchased a new stake in shares of Henry Schein during the fourth quarter worth about $32,000. Venturi Wealth Management LLC grew its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC increased its holdings in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC raised its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after purchasing an additional 143 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.